Auctus Advisors’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
Other funds holding CATX
Auctus Advisors's CATX Position: Q3 2026 in Review
Auctus Advisors increased its Perspective Therapeutics (CATX) stake by 84% in Q3 2026, buying an estimated $51.6K and bringing the position to 37,359 shares worth $103K. The position accounts for 0.08% of the portfolio, ranked #30.
Auctus Advisors first reported a position in CATX in Q4 2025 and has held it in 4 quarters since. 120 funds tracked by Wall St. Rank hold CATX as of Q3 2026.
- Auctus Advisors held 37,359 shares of Perspective Therapeutics worth $103K as of Q3 2026.
- Auctus Advisors bought 17,015 Perspective Therapeutics shares in Q3 2026, an estimated $51.6K.
- Perspective Therapeutics made up 0.08% of Auctus Advisors's portfolio in Q3 2026, its #30 holding.
- Auctus Advisors first reported a position in Perspective Therapeutics in Q4 2025 and has held it in 4 quarters since.
- 120 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2026.
Based on Auctus Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.